	Comparative effectiveness of immunotherapeutic regimens for untreated advanced non-small-cell lung cancer in real-world clinical practice: a Japanese cancer registry cohort study. ESMO Real World Data Digit Oncol Miyazaki A, Kunimasa K, Morishima T, Tamiya M, Inoue T, Kawamura T, Tanaka T, Komuta K, Futamura S, Nishino K, Miyashiro I. PMID: 41647721 [PubMed]
	Observational study on the safety and effectiveness of SARS-CoV-2 vaccination in patients with lung cancer. ESMO Real World Data Digit Oncol Nadal E, Morán T, Estival A, Sala MÁ, Antoñanzas M, González JG, Diz-Taín MP, Martínez M, Azcona E, Baena J, Campos B, Cumplido JD, Cerezo S, Díaz-Serrano A, Guirado M, Mielgo X, Saigí M, Vidales Z, Spanish Lung Cancer Group. PMID: 41647715 [PubMed]
	Eligibility for Lung Cancer Screening in Switzerland: A Comparative Analysis of Three Data Sources From Lausanne and the Canton of Vaud. Int J Public Health Gros L, Schneider C, Meyer ML, Korber J, Henchoz Y, Vaucher J, Marques-Vidal P, Ten Haaf K, Pozzessere C, Bongard C, Von Garnier C, Bulliard JL, Selby K. PMID: 41647684 [PubMed - indexed for MEDLINE]
	Definitions, measurement, and reporting of progression-free survival in randomized clinical trials and observational studies of patients with advanced non-small-cell lung cancer treated with immunotherapy: a scoping review. ESMO Real World Data Digit Oncol Verschueren MV, Tassopoulou VP, Visscher R, Schuurkamp J, Peters BJM, Koopman M, van de Garde EMW, Egberts ACG, Bloem LT. PMID: 41647347 [PubMed]
	Advances in the application of tumor vaccines and combination strategies: new perspectives in lung cancer treatment. Front Immunol Sun L, Zhao Q, Miao L. PMID: 41646963 [PubMed - indexed for MEDLINE]
	Clinical impact of first-line chemotherapy combined with immune checkpoint inhibitors for limited-stage small cell lung cancer patients: a real-world propensity score matching study. Front Immunol Hu Q, Zhou C, Zhao F, Song X, Ding Y, Wang X, Wu B, Wang H, Chen S, Jia B. PMID: 41646844 [PubMed - indexed for MEDLINE]
	A multimodal AI biomarker PATH-ORACLE improves prediction of recurrence in stage I lung adenocarcinoma. medRxiv Kilim O, Pipek O, Sztupinszki Z, Huebner A, Diossy M, Prosz A, Moore D, Jamal-Hanjani M, Hackshaw A, Fillinger J, Moldvay J, Csabai I, Swanton C, Szallasi Z. PMID: 41646758 [PubMed]
	A Tale of Two Diagnoses: Pulmonary Tuberculosis and Metastatic Lung Adenocarcinoma in a High-Risk Host. Cureus Vangala A, Modi SK, Acharya S, Shreya D, Arty F, Pinninty DK, Weiner SM, Shah SM. PMID: 41646577 [PubMed]
	A novel approach in the identification of microRNAs in malignant pleural effusion for lung cancer diagnosis. Oncol Rev Valencia-Cervantes J, Ramirez-Martínez G, Palacios-Arreola MI, Loaeza-Román A, Sierra-Vargas MP. PMID: 41646253 [PubMed]
	Safety evaluation of selective RET inhibitors in patients with lung cancer: a real-world pharmacovigilance study. Tumori Wang Y, Jiang W, Cheng Y, Dong Q, Ru J, Yu C, Shen J, Wu L. PMID: 41645938 [PubMed - as supplied by publisher]
	The Association of right atrium and sinoatrial node irradiation with atrial fibrillation and radiation-induced heart disease in non-small cell lung cancer. Acta Oncol Sander Graven-Nielsen C, Jakobsen Kragh A, Froberg Brøndum R, Milo ML, Skovmos Nielsen M, Ettrup-Christensen A, Lind Laursen K, Szejniuk WM. PMID: 41645869 [PubMed - indexed for MEDLINE]
	Digital Biomarkers for Precision Early Detection of Lung Cancer: Integrating AI-Driven Multi-Omics Into Clinical Pathways. Cancer Med Bu F, Ling ZQ. PMID: 41645653 [PubMed - indexed for MEDLINE]
	Improving lung cancer screening diagnostic efficiency. Curr Opin Pulm Med Caruso CR, Kim RY. PMID: 41645520 [PubMed - as supplied by publisher]
	Spectrum of KRAS variants in primary lung mucinous adenocarcinoma: implications for diagnosis, testing, and therapy. J Am Soc Cytopathol Htoo A, Malenie R, Xing J. PMID: 41644317 [PubMed - as supplied by publisher]
	Corrigendum to "Study of a supportive application with integrated patient-reported outcomes in patients with advanced pancreatic or lung cancer (BetterEveryDay)" [Eur. J. Oncol. Nurs. 76C [2025] 102898]. Eur J Oncol Nurs Rolin L, Hald C, Nielsen D, Theile S, Christiansen AB, Oksen MS, Lundstedt B, Tesfaldet M, Belli SL, Horsted CB, Johansen JS, Chen IM. PMID: 41644314 [PubMed - as supplied by publisher]
	Clinical Characteristics, Risk Factors, and Outcomes of Cancer and Non-Cancer Patients with Hospital-Acquired Pulmonary Embolism: A Retrospective Cohort Study. Ann Vasc Surg Fan J, Jiang P, Cui Y, Zhang Z, He J, Wang K, Sun J, Mei F. PMID: 41643846 [PubMed - as supplied by publisher]
	Primary pulmonary enteric adenocarcinoma: A single-institute retrospective study on its imaging classification and survival outcomes. Eur J Surg Oncol Du H, Li W, Wang J, Wu S, Song N, Wan Z, Shi J, Wu F. PMID: 41643628 [PubMed - as supplied by publisher]
	Prognostic value of the baseline triglyceride-glucose-body mass index in small cell lung cancer undergoing chemoimmunotherapy: A multicenter retrospective study. Cancer Treat Res Commun Zhu D, Guo Y, Liu W, Gong B, Li Y, Jiang S, Li Y, Miao L, Li L, Yang L. PMID: 41643283 [PubMed - as supplied by publisher]
	Targeted Protein Degradation Strategies for Lung Cancers: Focusing on Epidermal Growth Factor Receptor. Chem Biodivers Hou M, Li M, Zhao J, Gong Y, Rong J, Feng Z, Sun H, Zeng J. PMID: 41643153 [PubMed - indexed for MEDLINE]
	Navigating the Complexity of Lung Cancer Surveillance Practices: Qualitative Pilot Study on Provider Perspectives. JMIR Cancer Woo JM, Conover S, Gray C, Arya S, Wu JT. PMID: 41643130 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 157016

Page 1 of 7851



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy